VFC vs ZYME · P/E 26, rev $9.50B vs rev $76.3M
VF Corporation (VFC) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
VF Corporation (VFC) is a apparel manufacturing company listed on NYSE.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported VFC revenue for 2025-03-29 was $9.50B. Net income was -$189.7M. Revenue was down 4.1% from 2024-03-30 to 2025-03-29. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
VFC currently screens at market cap $6.55B and trailing P/E 26.1. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the VFC and ZYME stock pages for the full models.
Not investment advice.